CalciMedica, Inc. — Investor Relations & Filings
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for acute inflammatory and immunologic diseases. The company specializes in the inhibition of calcium release-activated calcium (CRAC) channels, a therapeutic approach designed to modulate the immune response and protect against tissue cell injury. Its lead product candidate, Auxora™, is an intravenous formulation of the proprietary small molecule CRAC channel inhibitor, zegocractin. CalciMedica is developing Auxora for the treatment of life-threatening conditions with high unmet medical needs, including acute kidney injury (AKI) with respiratory failure and acute pancreatitis (AP), for which there are currently no approved disease-modifying treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - CalciMedica, Inc. (0001534133) (Filer) | 2026-05-12 | English | |
| 10-K/A - CalciMedica, Inc. (0001534133) (Filer) | 2026-04-30 | English | |
| S-3 - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | |
| 10-K - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | |
| 8-K - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | |
| SCHEDULE 13G/A Filing | 2026-02-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 45231608 | 8-K - CalciMedica, Inc. (0001534133) (Filer) | 2026-05-12 | English | ||
| 39208161 | 10-K/A - CalciMedica, Inc. (0001534133) (Filer) | 2026-04-30 | English | ||
| 32893525 | S-3 - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | ||
| 32893526 | 10-K - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | ||
| 32893524 | 8-K - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | ||
| 30430142 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 30430167 | 8-K Filing | 2026-01-28 | English | ||
| 30430145 | 8-K Filing | 2026-01-28 | English | ||
|
2025
7 filings
| |||||
| 12507329 | Major Shareholding Notification 2025 | 2025-12-01 | English | ||
| 12507327 | 10-Q | 2025-11-12 | English | ||
| 12507326 | 8-K | 2025-11-12 | English | ||
| 12507328 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 12507330 | 8-K | 2025-11-06 | English | ||
| 12507332 | 424B5 | 2025-11-06 | English | ||
| 12507334 | Major Shareholding Notification 2025 | 2025-10-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
CalciMedica, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34649/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34649 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34649 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34649 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34649}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CalciMedica, Inc. (id: 34649)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.